Annual Retained Earnings
-$1.49 B
-$143.10 M-10.65%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual retained earnings is -$1.49 billion, with the most recent change of -$143.10 million (-10.65%) on December 31, 2023.
- During the last 3 years, KPTI annual retained earnings has fallen by -$417.43 million (-39.03%).
- KPTI annual retained earnings is now -11577.70% below its all-time high of -$12.73 million, reached on December 31, 2011.
Performance
KPTI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.53 B
-$32.07 M-2.14%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly retained earnings is -$1.53 billion, with the most recent change of -$32.07 million (-2.14%) on September 30, 2024.
- Over the past year, KPTI quarterly retained earnings has dropped by -$32.07 million (-2.14%).
- KPTI quarterly retained earnings is now -5254.90% below its all-time high of -$28.62 million, reached on December 31, 2012.
Performance
KPTI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
KPTI Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.7% | -2.1% |
| 3 y3 years | -39.0% | -25.9% |
| 5 y5 years | -120.7% | -85.8% |
KPTI Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.2% | at low | -30.0% | at low |
| 5 y | 5-year | -70.3% | at low | -75.5% | at low |
| alltime | all time | <-9999.0% | at low | -5254.9% | at low |
Karyopharm Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.53 B(+2.1%) |
| Jun 2024 | - | -$1.50 B(-1.6%) |
| Mar 2024 | - | -$1.52 B(+2.5%) |
| Dec 2023 | -$1.49 B(+10.6%) | -$1.49 B(+2.9%) |
| Sep 2023 | - | -$1.45 B(+2.4%) |
| Jun 2023 | - | -$1.41 B(+2.4%) |
| Mar 2023 | - | -$1.38 B(+2.5%) |
| Dec 2022 | -$1.34 B(+14.0%) | -$1.34 B(+2.9%) |
| Sep 2022 | - | -$1.31 B(+2.9%) |
| Jun 2022 | - | -$1.27 B(+4.0%) |
| Mar 2022 | - | -$1.22 B(+3.5%) |
| Dec 2021 | -$1.18 B(+10.2%) | -$1.18 B(-3.2%) |
| Sep 2021 | - | -$1.22 B(+4.4%) |
| Jun 2021 | - | -$1.17 B(+4.8%) |
| Mar 2021 | - | -$1.11 B(+4.0%) |
| Dec 2020 | -$1.07 B(+22.5%) | -$1.07 B(+4.2%) |
| Sep 2020 | - | -$1.03 B(+5.5%) |
| Jun 2020 | - | -$972.70 M(+5.0%) |
| Mar 2020 | - | -$926.27 M(+6.1%) |
| Dec 2019 | -$873.34 M(+29.6%) | -$873.34 M(+5.9%) |
| Sep 2019 | - | -$824.69 M(+5.3%) |
| Jun 2019 | - | -$783.32 M(+5.9%) |
| Mar 2019 | - | -$739.91 M(+9.8%) |
| Dec 2018 | -$673.75 M | -$673.75 M(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$615.54 M(+8.5%) |
| Jun 2018 | - | -$567.45 M(+6.3%) |
| Mar 2018 | - | -$533.80 M(+7.8%) |
| Dec 2017 | -$495.34 M(+35.3%) | -$495.34 M(+8.6%) |
| Sep 2017 | - | -$456.30 M(+7.2%) |
| Jun 2017 | - | -$425.66 M(+7.4%) |
| Mar 2017 | - | -$396.27 M(+8.2%) |
| Dec 2016 | -$366.10 M(+42.7%) | -$366.10 M(+7.9%) |
| Sep 2016 | - | -$339.17 M(+8.1%) |
| Jun 2016 | - | -$313.74 M(+10.6%) |
| Mar 2016 | - | -$283.59 M(+10.5%) |
| Dec 2015 | -$256.53 M(+85.4%) | -$256.53 M(+12.8%) |
| Sep 2015 | - | -$227.48 M(+15.4%) |
| Jun 2015 | - | -$197.11 M(+19.9%) |
| Mar 2015 | - | -$164.41 M(+18.8%) |
| Dec 2014 | -$138.35 M(+121.1%) | -$138.35 M(+23.1%) |
| Sep 2014 | - | -$112.42 M(+21.3%) |
| Jun 2014 | - | -$92.69 M(+21.5%) |
| Mar 2014 | - | -$76.26 M(+21.9%) |
| Dec 2013 | -$62.57 M(+118.6%) | -$62.57 M(+24.1%) |
| Sep 2013 | - | -$50.42 M(+22.7%) |
| Jun 2013 | - | -$41.10 M(+43.6%) |
| Dec 2012 | -$28.62 M(+124.8%) | -$28.62 M |
| Dec 2011 | -$12.73 M | - |
FAQ
- What is Karyopharm Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual retained earnings year-on-year change?
- What is Karyopharm Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly retained earnings year-on-year change?
What is Karyopharm Therapeutics annual retained earnings?
The current annual retained earnings of KPTI is -$1.49 B
What is the all time high annual retained earnings for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual retained earnings is -$12.73 M
What is Karyopharm Therapeutics annual retained earnings year-on-year change?
Over the past year, KPTI annual retained earnings has changed by -$143.10 M (-10.65%)
What is Karyopharm Therapeutics quarterly retained earnings?
The current quarterly retained earnings of KPTI is -$1.53 B
What is the all time high quarterly retained earnings for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly retained earnings is -$28.62 M
What is Karyopharm Therapeutics quarterly retained earnings year-on-year change?
Over the past year, KPTI quarterly retained earnings has changed by -$32.07 M (-2.14%)